Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bevacizumab in the treatment of hereditary hemorrhagic telangiectasia.

Expert opinion on biological therapy - 1 Sept 2013

Kanellopoulou Theoni, Alexopoulou Alexandra

Abstract excerpt

INTRODUCTION: Hereditary hemorrhagic telangiectasia (HHT) is a rare multisystem vascular disorder characterized by epistaxis, mucocutaneous telangiectases and visceral arteriovenous malformations predisposing to shunting and hemorrhage. Angiogenesis has been implicated in the pathogenesis of HHT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Angiogenesis Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibodies, Monoclonal, Humanized

Share to Bevacizumab

Share to Mutation

Share to Telangiectasia, Hereditary Hemorrhagic

Source

Identifiers

PMID: 23815519
DOI: 10.1517/14712598.2013.813478

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23815519-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bevacizumab in the treatment of hereditary hemorrhagic telangiectasia.PMID 23815519Read ↗

Abnormal Angiogenesis and Therapeutic Targeting of VEGF, FGFR and PI3K/AKT/mTOR Signalling Pathways in Hereditary Haemorrhagic Telangiectasia: A Translational Narrative ReviewSemantic proximity Read ↗

Molecular mechanisms and clinical manifestations of hereditary hemorrhagic telangiectasia.Semantic proximity Read ↗

Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective.Semantic proximity Read ↗

Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions.Semantic proximity Read ↗

Tacrolimus as a Promising Drug for Epistaxis and Gastro Intestinal Bleeding in HHTSemantic proximity Read ↗

Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures.Semantic proximity Read ↗

Future treatments for hereditary hemorrhagic telangiectasiaSemantic proximity Read ↗

Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasiaSemantic proximity Read ↗

Beyond Epistaxis: Cascade Screening and Presymptomatic Treatment of Hereditary Hemorrhagic TelangiectasiaSemantic proximity Read ↗

Clinical presentation and treatment paradigms of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.Semantic proximity Read ↗

[Hereditary hemorrhagic telangiectasia].Semantic proximity Read ↗

Hereditary haemorrhagic telangiectasia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.